Amnestic MCI patients’ experiences after disclosure of their amyloid PET result in a research context

BACKGROUND: Biomarkers such as amyloid imaging are increasingly used for diagnosis in the early stages of Alzheimer’s disease. Very few studies have examined this from the perspective of the patient. To date, there is only limited evidence about how patients experience and value disclosure in an ear...

Descripción completa

Detalles Bibliográficos
Autores principales: Vanderschaeghe, Gwendolien, Schaeverbeke, Jolien, Bruffaerts, Rose, Vandenberghe, Rik, Dierickx, Kris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5712105/
https://www.ncbi.nlm.nih.gov/pubmed/29197423
http://dx.doi.org/10.1186/s13195-017-0321-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5712105/
https://www.ncbi.nlm.nih.gov/pubmed/29197423
http://dx.doi.org/10.1186/s13195-017-0321-3

Ejemplares similares